Enhancing RAI Incorporation in Refractory Thyroid Cancer
The article discusses the mechanisms of resistance to radioactive iodine (RAI) therapy in differentiated thyroid cancer (DTC), particularly in patients with distant metastases. Key factors contributing to RAI resistance include genetic mutations in …